The Monitoring Messenger: Mobile Patient Monitoring for the Pediatric Intensive Care Unit

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by University of British Columbia
Sponsor:
Information provided by (Responsible Party):
University of British Columbia
ClinicalTrials.gov Identifier:
NCT01612091
First received: June 1, 2012
Last updated: March 18, 2014
Last verified: March 2014

June 1, 2012
March 18, 2014
November 2013
April 2015   (final data collection date for primary outcome measure)
Accuracy of priority assignment in triaging task [ Time Frame: Up to 1 hour ] [ Designated as safety issue: No ]
Accuracy will be measured by matching of the participants triage priority ranking with the previously defined expert ranking.
Same as current
Complete list of historical versions of study NCT01612091 on ClinicalTrials.gov Archive Site
Requirements for design of the mobile device [ Time Frame: Up to 2 hours ] [ Designated as safety issue: No ]
Information requirements for tasks, task frequencies, perceived challenges and potential suggestions to improve their current work environment using a mobile monitoring and messaging device
Same as current
Not Provided
Not Provided
 
The Monitoring Messenger: Mobile Patient Monitoring for the Pediatric Intensive Care Unit
The Monitoring Messenger: Mobile Patient Monitoring for the Pediatric Intensive Care Unit

The Mobile Messenger is a unified, portable and intelligent device that integrates information from multiple patient monitors, mechanical ventilators, infusion pumps and clinical information systems on a mobile platform. It will allow nurses, respiratory therapists and physicians to continuously monitor and coordinate care of critically ill patients. This study will use a participatory design process to guide the design of an integrated mobile device. Next, we will evaluate the proposed device in a simulated ICU setting.

There are a limited number of nurses, respiratory therapists and physicians in an ICU at a given time. To make decisions and plan therapies, these clinicians need to observe, assimilate and interpret a vast array of information originating from various devices located on the bedsides of multiple patients. Several shortcomings in existing technology limit their abilities: a) the fixed location of monitoring devices at the bedside; b) information overload from a multitude of devices, each with its own display; c) the lack of integration and interaction between these devices; d) the use of visually cumbersome displays, which were historically created for monitoring during anesthesia but never optimized for users in the ICU; and e) lack of context specific information (such as historical trends) to support patient data interpretation and clinical decision making.

This project proposes to address these challenges in ICU monitoring by developing a unified, portable, and intelligent device: the Monitoring Messenger. By integrating information from multiple monitoring devices, mechanical ventilators, infusion pumps and clinical information systems on a mobile device (tablet PC or smart phone); the Monitoring Messenger will allow nurses, respiratory therapists and physicians on or off-site, to continuously monitor critically ill patients, thereby increasing patient safety.

The proposed experiment will have two parts: Part I - Participatory design and Part II - Simulation Experiment.

In Part I - Participatory Design. Participatory design an inter-professional team of nurses, physicians, designers, engineers, and human factors experts will follow a user-centered design process to obtain the system requirements, and obtain feedback during the rapid prototyping phase of prototype development. While we expect the resulting prototype to be easy to use, support decision making, improve awareness of the patient's condition by health care providers and reduce mental workload, this methodology is not hypothesis driven.

Part II - Simulation Experiment. In simulated ICU scenarios, the critical care physicians, nurses, and respiratory therapists will prioritize the care of critically ill patients. We expect them to do so more accurately with the use of Monitoring Messenger than with their regular tool (monitors, paper records etc). A potential outcome would be a decrease in mental workload as well as an increase in situational awareness.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Basic Science
  • To Guide the Design of the Mobile Device Using a Participatory Design Process With PICU Nurses, Respiratory Therapists and Physicians.
  • To Evaluate the Efficacy of the Mobile Messenger in Helping Nurses, Respiratory Therapists and Physicians Triage Simulated Patients.
Device: Monitoring Messenger
Monitoring Messenger prototype device
  • Experimental: Monitoring Messenger
    Intervention: Device: Monitoring Messenger
  • Active Comparator: Control
    Traditional tools (monitors, paper records)
    Intervention: Device: Monitoring Messenger
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
25
April 2015
April 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Staff pediatric critical care physicians, pediatric critical care fellow physicians, registered pediatric nurses and respiratory therapists will be eligible to participate in this study
  • Subjects willing to provide informed consent

Exclusion Criteria:

  • Inability/failure to provide informed consent.
  • Nursing students and resident physicians are not eligible
  • For Part II - Simulation Experiment only: Failure to complete the post-training quiz more than twice.
  • Evaluation will be immediately discontinued at request of subject at any point during the study.
Both
18 Years and older
Yes
Contact: Matthias Görges, PhD mgorges@cw.bc.ca
Canada
 
NCT01612091
H12-01270
No
University of British Columbia
University of British Columbia
Not Provided
Principal Investigator: Mark Ansermino, MBBCh, FRCPC The University of British Columbia
University of British Columbia
March 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP